Mild isn’t a synonym of safe 🧵
Many recent H5N1 cases in humans have been described as mild.
On the surface, this might sound reassuring, especially for a virus historically associated with a fatality rate of 50-60%.
But make no mistake.
This isn’t good news.
1/
Many recent H5N1 cases in humans have been described as mild.
On the surface, this might sound reassuring, especially for a virus historically associated with a fatality rate of 50-60%.
But make no mistake.
This isn’t good news.
1/
This is a red flag that the virus is adapting to human biology.
The slow creep of H5N1 human cases is a silent alarm few are hearing, and even fewer are prepared to confront.
What began as a virus largely confined to birds is now repeatedly spilling over into humans.
2/
The slow creep of H5N1 human cases is a silent alarm few are hearing, and even fewer are prepared to confront.
What began as a virus largely confined to birds is now repeatedly spilling over into humans.
2/
While the number of human infections remains relatively low, the virus is signaling its intent to evolve.
When zoonotic viruses accumulate cases in humans, the odds of a devastating pandemic skyrocket.
Mild isn’t a synonym of safe.
3/
When zoonotic viruses accumulate cases in humans, the odds of a devastating pandemic skyrocket.
Mild isn’t a synonym of safe.
3/
Pathogens like H5N1 face a critical evolutionary bottleneck when they jump from animals to humans.
Avian influenza strains are finely tuned to infect birds, where the virus binds to alpha-2,3-linked sialic acid receptors, predominantly found in avian respiratory tracts.
4/
Avian influenza strains are finely tuned to infect birds, where the virus binds to alpha-2,3-linked sialic acid receptors, predominantly found in avian respiratory tracts.
4/
Humans have alpha-2,6-linked sialic acid receptors in their upper respiratory tracts.
This difference is a barrier but not an insurmountable one.
With enough human infections, the virus can acquire mutations that improve its binding affinity for human receptors, allowing it to replicate more efficiently in human airways.
5/
This difference is a barrier but not an insurmountable one.
With enough human infections, the virus can acquire mutations that improve its binding affinity for human receptors, allowing it to replicate more efficiently in human airways.
5/
When a virus shifts its tropism, it sometimes reduces its lethality.
Temporarily.
Killing a host too quickly is counterproductive if the virus’s goal is to spread.
Recent “mild” H5N1 cases likely reflect this evolutionary trade-off.
The virus is adapting, trying to find the perfect balance between transmissibility and virulence.
And history tells us that once a virus gets a foothold in human populations, it doesn’t stay mild for long.
6/
Temporarily.
Killing a host too quickly is counterproductive if the virus’s goal is to spread.
Recent “mild” H5N1 cases likely reflect this evolutionary trade-off.
The virus is adapting, trying to find the perfect balance between transmissibility and virulence.
And history tells us that once a virus gets a foothold in human populations, it doesn’t stay mild for long.
6/
The 1918 influenza pandemic was caused by an H1N1 virus.
The initial wave of infections in early 1918 was relatively mild, with symptoms similar to seasonal flu.
Soldiers called it the “three-day fever” because most recovered quickly.
But the virus didn’t stop there.
As it spread through crowded military camps and cities, it mutated, emerging in the fall as a strain capable of causing catastrophic viral pneumonia and death.
By the end of 1919, the virus had killed an estimated 50 million people, many of them young and healthy.
7/
The initial wave of infections in early 1918 was relatively mild, with symptoms similar to seasonal flu.
Soldiers called it the “three-day fever” because most recovered quickly.
But the virus didn’t stop there.
As it spread through crowded military camps and cities, it mutated, emerging in the fall as a strain capable of causing catastrophic viral pneumonia and death.
By the end of 1919, the virus had killed an estimated 50 million people, many of them young and healthy.
7/
Now let’s talk about H5N1.
Unlike the 1918 H1N1 strain, which started mild and gained lethality over time, H5N1 begins with a much deadlier baseline.
Its historic case fatality rate of over 50% is already terrifying.
If a pandemic strain were to emerge, it wouldn’t need to be that lethal to cause devastation.
Even if it dropped to a 1-2% fatality rate its ability to overwhelm healthcare systems and cause societal disruption would be unparalleled.
But if it retains even a fraction of its current lethality (say, 10%) the death toll would be unimaginable.
8/
Unlike the 1918 H1N1 strain, which started mild and gained lethality over time, H5N1 begins with a much deadlier baseline.
Its historic case fatality rate of over 50% is already terrifying.
If a pandemic strain were to emerge, it wouldn’t need to be that lethal to cause devastation.
Even if it dropped to a 1-2% fatality rate its ability to overwhelm healthcare systems and cause societal disruption would be unparalleled.
But if it retains even a fraction of its current lethality (say, 10%) the death toll would be unimaginable.
8/
The 2009 H1N1 pandemic offers another critical lesson.
While its fatality rate was low, its global spread was astonishingly fast due to its efficient human-to-human transmission.
Within weeks of its emergence, it had circled the globe.
Now imagine a virus with the transmissibility of 2009 H1N1 but the lethality of H5N1.
That’s not a hypothetical scenario if H5N1 continues to adapt in humans.
9/
While its fatality rate was low, its global spread was astonishingly fast due to its efficient human-to-human transmission.
Within weeks of its emergence, it had circled the globe.
Now imagine a virus with the transmissibility of 2009 H1N1 but the lethality of H5N1.
That’s not a hypothetical scenario if H5N1 continues to adapt in humans.
9/
It’s crucial to understand that “mild” is relative.
The current “mild” cases of H5N1 may simply mean that the virus is still inefficient in humans, infecting only the upper respiratory tract or triggering a less severe immune response.
10/
The current “mild” cases of H5N1 may simply mean that the virus is still inefficient in humans, infecting only the upper respiratory tract or triggering a less severe immune response.
10/
The concept of “mild” also obscures the virus’s potential to diversify.
H5N1 could take multiple evolutionary paths simultaneously.
Some lineages might prioritize spread, while others retain their lethality.
And here’s the thing: viruses don’t “choose” their trajectory.
They evolve based on chance and environmental pressures.
With every human case, H5N1 is essentially buying more lottery tickets in the pandemic mutation game.
11/
H5N1 could take multiple evolutionary paths simultaneously.
Some lineages might prioritize spread, while others retain their lethality.
And here’s the thing: viruses don’t “choose” their trajectory.
They evolve based on chance and environmental pressures.
With every human case, H5N1 is essentially buying more lottery tickets in the pandemic mutation game.
11/
History is clear: humanity doesn’t excel at responding to pandemics until it’s too late.
An H5N1 pandemic wouldn’t just strain healthcare systems.
It would break them.
12/12
An H5N1 pandemic wouldn’t just strain healthcare systems.
It would break them.
12/12
• • •
Missing some Tweet in this thread? You can try to
force a refresh
